SM

Swati Mylavarapu

North America, California, United States, San Francisco

Description

Swati Mylavarapu is the Managing Partner at Incite.org and Co-Founder and Board Chair of The Arena. She joined KPCB in 2015 and focuses on v...

Investor Profile

Swati Mylavarapu has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Seed (50%)
  • Series A (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Clinical Trials
  • Emergency Medicine
  • Health Care
  • Medical
  • Therapeutics
  • Finance
  • Financial Services
  • Fintech
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Swati Mylavarapu frequently co-invest with?

Kleiner Perkins
North America, California, United States, Menlo Park
Co-Investments: 1
Album VC
North America, Utah, United States, Lehi
Co-Investments: 1
SOSV
North America, New Jersey, United States, Princeton
Co-Investments: 1
Refactor
North America, California, United States, Burlingame
Co-Investments: 1
OA
North America, New York, United States, New York
Co-Investments: 1
SV Angel
North America, California, United States, San Francisco
Co-Investments: 1
CSC Upshot
North America, California, United States, Palo Alto
Co-Investments: 1
SV Tech Ventures
North America, California, United States, Palo Alto
Co-Investments: 1

Which angels does Swati Mylavarapu often collaborate with?

JA
North America, California, United States, San Francisco
Shared Deals: 1
PB
North America, California, United States, Mountain View
Shared Deals: 1
NK
North America, California, United States, Portola Valley
Shared Deals: 1
MR
North America, California, United States, San Francisco
Shared Deals: 2
TG
North America, California, United States, San Francisco
Shared Deals: 1
SA
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Swati Mylavarapu?

ANA Therapeutics

Foster City, California, United States

ANA Therapeutics is a biotech company that is developing a novel coronavirus vaccine intended to save human lives.

BiotechnologyClinical TrialsEmergency MedicineHealth CareMedicalTherapeutics
SeedAug 4, 2020
Amount Raised: $5,000,000
Nav

Draper, Utah, United States

Nav bridges the gap between SMB and financial institutions by bringing transparency, certainty, and efficiency to B2B credit and financing.

FinanceFinancial ServicesFinTech
Series ANov 28, 2015
Amount Raised: $8,370,504